Le Lézard
Classified in: Health
Subjects: TDS, FVT

Qfix® Revolutionizes Adaptive Thermoplastic Masks for Intracranial, Head and Neck Cancer Treatment


AVONDALE, Pa., Oct. 19, 2018 /PRNewswire/ -- Qfix introduces a new line of thermoplastic masks for fractionated intracranial head and neck cancer treatments. Over the course of treatment, patient anatomy can change due to various medications and treatment side effects. The patent pending Integrated Shimtm system for Portraittm S-frames maximizes comfort to the patient while minimizing motion during dose distribution.

"Integrated Shimtm provides a more precise tool to enhance patient comfort and workflow efficiencies," stated Vicqui Yu, Product Manager for Qfix. "By integrating the shims into the mask frame, the treatment team can adjust the tightness of the custom formed thermoplastic without having to add or remove shim material manually. Each pin can be tightened or loosened in half millimeter increments, fine tuning each mask to the patient's changing needs."

Integrated Shimtm is offered in a variety of styles, utilizing both Aquaplast RTtm and Fibreplast® thermoplastic material. The newly designed Integrated Shimtm masks are now available in both head only and head and shoulder styles.

Portraittm S-frames with Integrated Shimtm will be on display and used in live demonstrations at the Qfix Booth #1913 during the American Society for Radiation Oncology (ASTRO) annual meeting, October 21 - 24, 2018.

About Qfix

Qfix is a world leader in radiotherapy dedicated to helping medical professionals provide the best patient care with the world's finest positioning devices designed to enhance the probability of positive patient outcomes. For more information, visit www.Qfix.com.

 

SOURCE Qfix


These press releases may also interest you

at 17:00
Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private...

at 16:46
Darling Ingredients Inc. announced today that it will host a conference call on Thursday, April 25, 2024, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2024 financial results, which will be released earlier that day, and...

at 16:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...

at 16:45
Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 243,000 shares of Geron common stock as inducements to newly hired employees in connection...

at 16:35
DermTech, Inc. (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board of directors engaged TD Cowen to conduct a process exploring...

at 16:33
A bill named in memory of four-year-old Ana Lucía "Lulu" Haynes, who passed away from sepsis in 2014, has been reintroduced in the House of Representatives. It arrives ahead of next week's Pediatric Sepsis Week observance, which provides an annual...



News published on and distributed by: